Long-term phase: Randomisation and first follow-up visits

At your second scheduled study visit (the randomisation visit), if you proceed into the long-term part of the study, you will be randomly allocated to receive pills containing either 
BI 690517 10mg or matching placebo.

At the randomisation visit you will be issued one pack of Type M Randomised Treatment containing one bottle (112 pills) of study treatment and one pack of Type E Treatment containing one wallet (112 pills) of empagliflozin 10mg.

No study treatment will be issued at the bloods only (one to three weeks) and first
follow-up visit (one-month).

At the second follow-up visit (three months) you will also be issued one pack of Type M Randomised Treatment containing one bottle (112 pills) of study treatment and one pack of Type E Treatment containing one wallet (112 pills) of empagliflozin 10mg.